News About: Pharm. Industry
Korean firms urged to seek overseas expansion
Domestic drugmakers will ramp up their overseas expansion drive as tightening regulations and cut-to-throat competition make the future growth of the local pharmaceutical industry unpredictable, experts sad.
The co...
New incentive system for medical institutions should be overhauled
The pharmaceutical industry in large is skeptical of the new system aiming to punish both the briber and recipient and reimburse buyers 70 percent of the price differential when they buy prices below the government-fi...
Korea’s leading drug manufacturers feel pinch in prescription drug sales
Last year, the leading domestic drug makers were significantly affected by the government’s policy to abandon rebate, defined by a kind of kickback given by drug companies to pharmacies, clinics and hospital for buyin...
Competition to get fiercer for Olmetec generic market
Korean companies are poised to step up their marketing in domestic Olmetec generics market, which is forecast to become more competitive than even early this year, according to industry source.
The Korea Food and D...
Merck Serono salespersons set to use iPad in sales field
Merck-Serono Korea, the affiliate of the global pharmaceutical and chemical behemoth here, says it has provided to its marketing and sales team the Apple iPad, a tablet computer optimized for Internet browsing, media ...
Antiplatelet drug market to face big transition
The domestic antiplatelet drugs market will undergo a major transformation as AstraZenca is set to launch its new platelet aggregation inhibitor Brilinta (ticagrelor) in the latter half of this year.
So far, Sanofi...
Dongwha, Novartis Korea sign OTC deal
Dongwha Pharmaceutical and Novartis Korea recently established a strategic alliance to co-market the whole range of the latter’s over-the-counter (OTC) drugs in Korea.
These OTC medicines include Lamisil (terbinaf...
Chong Kun Dang’s antihypertensive Dilatrend sales top 66 billion won
Pfizer’s Norvask (amlodipine mesilate) has boasted the highest annual revenue in Korea’s competitive hypertensive market for the past years. But last year, the company’s flagship product is being challenged by Chong ...
Pharmaceutical firms oppose DTC prescription drug ads
Korean drug companies are skeptical over the government’s plan to allow the direct to consumer prescription drug advertising, citing the clash between doctors and pharmacists over who gets the right to prescribe medic...
BioAsia 2011 helps Korean companies enhance mutual cooperation with Indian companies
The Global BioBusiness Forum, BioAsia 2011, is expected to help Korean companies accelerate their inroads into Asia's fourth-largest economy and solidify their presence there, the Korea Drug Research Association said ...
